General MedicationsINTRAVENOUSStandard
IOFLUPANE I-123
IOFLUPANE I-123
Standard Dose
5mCi/2.5ML (2mCi/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview IOFLUPANE I-123 is listed in Drugs@FDA under application 213792 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient IOFLUPANE I-123 Form and strength SOLUTION;INTRAVENOUS - 5mCi/2.5ML (2mCi/ML) Sponsor CURIUM Submission history Latest submission status date: 2023-09-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview IOFLUPANE I-123 is listed in Drugs@FDA under application 213792 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IOFLUPANE I-123 Form and strength SOLUTION;INTRAVENOUS - 5mCi/2.5ML (2mCi/ML) Sponsor CURIUM Submission history Latest submission status date: 2023-09-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.